FCA moratorium on publication of resultsSource: RNS
Financial Conduct Authority ("FCA") moratorium on publication of results
Smiths Group plc
Following FCA and Financial Reporting Council ("FRC") announcements covering all UK-listed companies, Smiths Group plc today announces a delay in the publication of its interim financial results.
Smiths Group plc was ready to release its interim results on 31 March 2020. However, in the light of COVID-19, the FCA requested that all listed companies observe a moratorium on the publication of preliminary financial statements until at least 6 April 2020. The FRC subsequently issued guidance that the moratorium should be extended to interim financial results. Smiths Group plc will be observing this moratorium and instead intends to provide a trading update on 31 March 2020, but will not be holding the scheduled analysts' conference call.
It is expected that the interim financial results will be published on 6 April 2020, subject to any further announcements from the FCA and FRC. Smiths plans to hold an analysts' conference call following the publication of the interim results.
Marion Le Bot, Smiths Group
+44 (0)20 7004 1672
+44 (0)75 8315 4386
Deborah Scott, FTI Consulting
+44 (0)20 3727 1459
+44 (0)797 953 7449
Alex Le May, FTI Consulting
+44 (0)20 3727 1308
+44 (0)7702 443 312
Legal Entity Identifier (LEI): 213800MJL6IPZS3ASA11
About Smiths Group plc
Smiths is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). Its businesses share common characteristics (well-positioned in growing markets, technology-led, asset-light, digitising, with a high proportion of aftermarket revenues) and a common operating model (The Smiths Excellence System). For more information visit www.smiths.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact email@example.com or visit www.rns.com.